| 130 | To reduce the subjective symptoms and objective signs of cervical dystonia (spasmodic torticollis) in adults. |
| | LU Authorization Period: 1 year |
| 412 | For the management of focal spasticity, due to stroke or spinal cord injury in adults. |
| | LU Authorization Period: 1 year |
| 421 | For the treatment of blepharospasm associated with dystonia, including benign essential blepharospasm or VII nerve disorders in adults. |
| | LU Authorization Period: 1 year |
| | NOTE: Xeomin should be administered personally by a neurologist or a physician with equivalent post-graduate training and experience with neuromuscular disorders. |
